⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL15062777 | 0.89 | TSHR (0.39) | — | |
| SCHEMBL4535567 | 0.86 | — | — | |
| SCHEMBL4623787 | 0.84 | HRH3 (0.47) | — | |
| SCHEMBL7172295 | 0.84 | MAOA (0.42) | — | |
| SCHEMBL5251062 | 0.82 | HRH1 (0.48) | — | |
| SCHEMBL30877273 | 0.80 | — | — | |
| SCHEMBL7003873 | 0.79 | GPR84 (0.41) | — | |
| SCHEMBL1697090 | 0.79 | — | — | |
| SCHEMBL79201 | 0.78 | MAOA (0.47) | — | |
| SCHEMBL25422764 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240092780-A1 | ADDUCTS AND DIMER COMPOUNDS SYNTHESIZED USING GK METHOD | ANKH LIFE SCIENCES LIMITED (IE) | 2024-03-21 | — | — | US | claimed |
| WO-2024050395-A1 | ADDUCTS AND DIMER COMPOUNDS SYNTHESIZED USING GK METHOD | ANKH LIFE SCIENCES LIMITED (IE) | 2024-03-07 | — | — | WO | claimed |
| US-12358399-B2 | Monitoring health of heat transfer fluids for electric systems | ExxonMobil Technology and Engineering Company (US) | 2025-07-15 | — | — | US | disclosed |
| CN-115605374-B | Condition monitoring of heat transfer fluid for electrical systems | 埃克森美孚技术与工程公司 | 2024-12-17 | — | — | CN | disclosed |
| US-12145913-B2 | Inhibition of Olig2 activity | Curtana Pharmaceuticals, Inc. (US) | 2024-11-19 | — | — | US | disclosed |
| EP-4415561-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-08-21 | — | — | EP | disclosed |
| US-20240092780-A1 | ADDUCTS AND DIMER COMPOUNDS SYNTHESIZED USING GK METHOD | ANKH LIFE SCIENCES LIMITED (IE) | 2024-03-21 | — | — | US | disclosed |
| CN-117106007-B | Loose lupeane derivative and application thereof in preparation of multi-target tumor angiogenesis and invasion metastasis inhibitor | 吉林农业大学 | 2024-03-19 | — | — | CN | disclosed |
| WO-2024050395-A1 | ADDUCTS AND DIMER COMPOUNDS SYNTHESIZED USING GK METHOD | ANKH LIFE SCIENCES LIMITED (IE) | 2024-03-07 | — | — | WO | disclosed |
| CN-117106007-A | Loose lupeane derivative and application thereof in preparation of multi-target tumor angiogenesis and invasion metastasis inhibitor | 吉林农业大学 | 2023-11-24 | — | — | CN | disclosed |
| US-20230166635-A1 | MONITORING HEALTH OF HEAT TRANSFER FLUIDS FOR ELECTRIC SYSTEMS | ExxonMobil Technology and Engineering Company (US) | 2023-06-01 | — | — | US | disclosed |
| WO-1993006198-A1 | OIL COMPOSITIONS | THE LUBRIZOL CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
| EP-0338989-B1 | HETEROTETRACYCLIC LACTAM DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CIBA-GEIGY AG (CH) | 1993-03-17 | — | — | EP | disclosed |
| US-4997832-A | Learning enhancement | CIBA-GEIGY CORPORATION (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0172692-B1 | HEXAHYDROINDOLIZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS AND INTERMEDIATES | McNeilab, Inc. (US) | 1990-04-18 | — | — | EP | disclosed |
| US-4897399-A | ALZHEIMER'S, NOOTROPIC AGENTS | CIBA-GEIGY CORP. (US) | 1990-01-30 | — | — | US | disclosed |
| EP-0338989-A1 | Heterotetracyclic lactam derivatives, process for their preparation, and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1989-10-25 | — | — | EP | disclosed |
| US-4788203-A | INHIBITING CALCIUM INDUCED CONTRACTION; USED IN CHEMOTHERAPHY TREATMENT | MERCK & CO., INC. (US) | 1988-11-29 | — | — | US | disclosed |
| EP-0172692-A1 | Hexahydroindolizine compounds, pharmaceutical compositions and methods and intermediates | McNeilab, Inc. (US) | 1986-02-26 | — | — | EP | disclosed |
| US-4572911-A | ANTISECRETORY AND ANTIDEPRESSANT AGENTS | MCNEILAB, INC. (US) | 1986-02-25 | — | — | US | disclosed |